Amniotics AB (OSTO:AMNI) Ending Cash Position : kr8.21 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Ending Cash Position?

Amniotics AB's Ending Cash Position for the quarter that ended in Dec. 2023 was kr8.21 Mil.

Amniotics AB's quarterly Ending Cash Position declined from Jun. 2023 (kr5.83 Mil) to Sep. 2023 (kr3.59 Mil) but then increased from Sep. 2023 (kr3.59 Mil) to Dec. 2023 (kr8.21 Mil).

Amniotics AB's annual Ending Cash Position declined from Dec. 2021 (kr43.98 Mil) to Dec. 2022 (kr9.10 Mil) and declined from Dec. 2022 (kr9.10 Mil) to Dec. 2023 (kr8.21 Mil).

Amniotics AB Ending Cash Position Historical Data

The historical data trend for Amniotics AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Ending Cash Position Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

0.51

43.98

9.10

8.21

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial										23.61	9.10	5.83	3.59	8.21

Amniotics AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Amniotics AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9.103	+	-0.891
	=	8.21

Amniotics AB's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	-11.98	+	20.192
	=	8.21

Amniotics AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.